beta

CLSN

Celsion Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Market Cap: 79.6 Million

Primary Exchange: NASDAQ

Website: http://www.celsion.com

Shares Outstanding: 27.8 Million

Float: 25.9 Million

Dividend: (%)

Beta: 0.202751554740997

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 2002 trading days

From: 2013-01-15 To: 2020-06-04

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-30 14.0 1.0 14.0
2013-10-29 4.5 1.0 4.5
Data provided by IEX Cloud